Li et al. [7] covered that the levels of MnSOD decreased to varying degrees in many diseases such as tumors, psoriasis, inflammatory bowel disease and neurodegenerative diseases; simultaneously, low levels of MnSOD can interrupt ROS signaling to suppress tumorigenesis, which may become a promising target for oncotherapy in the future. Here, SOD2 is linked to psoriasis.